{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:53:51Z","timestamp":1793332431745,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaad.2025.04.016","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T16:46:41Z","timestamp":1744303601000},"page":"457-465","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Summation and recommendations for the safe and effective use of topical and oral minoxidil"],"prefix":"10.1016","volume":"93","author":[{"given":"Elise A.","family":"Olsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Hordinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha A.","family":"Mesinkovska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Sadick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Bergfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2025.04.016_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/0003-4819-94-1-61","article-title":"Minoxidil","volume":"84","author":"Linas","year":"1981","journal-title":"Ann Int Med"},{"key":"10.1016\/j.jaad.2025.04.016_bib3","series-title":"FDA Package Insert On 2% Topical Minoxidil Solution","year":"1988"},{"key":"10.1016\/j.jaad.2025.04.016_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0190-9622(86)70138-2","article-title":"Dose-response study of topical minoxidil in male pattern baldness","volume":"15","author":"Olsen","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0190-9622(85)70157-0","article-title":"Topical minoxidil in early male pattern baldness","volume":"13","author":"Olsen","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-4362.1993.tb02755.x","article-title":"Use of topical minoxidil therapy for androgenetic alopecia in women","volume":"32","author":"Jacobs","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archderm.1994.01690030035005","article-title":"Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution","volume":"130","author":"DeVillez","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1067\/mjd.2002.124088","article-title":"A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men","volume":"47","author":"Olsen","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaad.2003.06.014","article-title":"A randomized placebo-controlled trial of 5% and 2% topical minoxidil solution in the treatment of androgenetic alopecia in females","volume":"50","author":"Lucky","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.jaad.2007.04.012","article-title":"A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men","volume":"57","author":"Olsen","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib11","first-page":"883","article-title":"Efficacy and safety of once-daily minoxidil foam 5% versus twice-daily minoxidil solution 2% in female pattern hair loss: a phase III, randomized, investigator-blinded study","volume":"15","author":"Blume-Peytavi","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0190-9622(87)70179-0","article-title":"Topical minoxidil in male pattern baldness: effects of discontinuation of treatment","volume":"17","author":"Olsen","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0190-9622(87)70089-9","article-title":"Long-term follow-up of men with male pattern baldness treated with topical minoxidil","volume":"16","author":"Olsen","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0190-9622(90)70089-Z","article-title":"Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil","volume":"22","author":"Olsen","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib15","unstructured":"Olsen EA, Whiting DA, Miller JJ. Increased frontal scalp coverage and frontal hair regrowth with 5% and 2% minoxidil topical solution. Poster presentation American Academy of Dermatology 61st Annual Meeting; March 2003; San Francisco."},{"key":"10.1016\/j.jaad.2025.04.016_bib16","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1111\/bjd.13399","article-title":"Similar response patterns to 5% topical minoxidil foam in frontal and vertex scalp of men with androgenetic alopecia: a microarray analysis","volume":"172","author":"Mirmirani","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib17","series-title":"The Minoxidil Millionaire","author":"Dorschrer","year":"1988"},{"key":"10.1016\/j.jaad.2025.04.016_bib18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0733-8635(18)30743-5","article-title":"Minoxidil","volume":"5","author":"Fiedler \u2013Weiss","year":"1987","journal-title":"Dermatol Clin"},{"issue":"3 Pt 2","key":"10.1016\/j.jaad.2025.04.016_bib19","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0190-9622(87)70095-4","article-title":"Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata","volume":"16","author":"Price","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0190-9622(96)90500-9","article-title":"A randomized trial of minoxidil in chemotherapy-induced alopecia","volume":"35","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib21","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40257-018-0409-y","article-title":"Off-label use of topical minoxidil in alopecia: a review","volume":"20","author":"Stoehr","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib22","first-page":"894","article-title":"The potential role of minoxidil in hair transplantation setting","volume":"28","author":"Avram","year":"2002","journal-title":"Dermatol Drug"},{"key":"10.1016\/j.jaad.2025.04.016_bib23","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.jaad.2004.12.029","article-title":"Short anagen syndrome","volume":"53","author":"Antaya","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib24","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1001\/archderm.138.4.501","article-title":"Is the loose anagen hair syndrome a keratin disorder? A clinical and molecular study","volume":"138","author":"Chapalain","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib25","doi-asserted-by":"crossref","first-page":"E139","DOI":"10.1016\/j.jaad.2012.10.019","article-title":"Topical minoxidil treatment for congenital hidrotic ectodermal dysplasia","volume":"68","author":"Lee","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib26","first-page":"146","article-title":"Safety and efficacy of minoxidil treatment in scarring alopecia: a scoping review","volume":"23","author":"Ly","year":"2024","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/ijt.ijt_19_20","article-title":"Effect of oral minoxidil for alopecia: systematic review","volume":"12","author":"do Nascimento","year":"2020","journal-title":"Int J Trichol"},{"key":"10.1016\/j.jaad.2025.04.016_bib28","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/jdv.17216","article-title":"Review of oral minoxidil as treatment of hair disorders: in search of the perfect dose","volume":"35","author":"Villani","year":"2021","journal-title":"Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2025.04.016_bib29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaad.2020.10.032","article-title":"Low-dose oral minoxidil for treating alopecia: a 3-year North American retrospective case series","volume":"84","author":"Beach","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/ijd.14933","article-title":"Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review","volume":"59","author":"Sharma","year":"2020","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib31","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaad.2024.11.048","article-title":"Tolerability and effectiveness of low-dose oral minoxidil for alopecia in patients with breast cancer: a retrospective cohort study","volume":"92","author":"Zaminski","year":"2025","journal-title":"J Am Acad"},{"issue":"1","key":"10.1016\/j.jaad.2025.04.016_bib32","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1111\/jdv.17623","article-title":"Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial","volume":"36","author":"Bokhari","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.jaad.2025.04.016_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/DSS.0000000000003866","article-title":"Intradermal delivery of alopecia therapeutics: current state and future prospects","volume":"49","author":"Alhanshali","year":"2023","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2025.04.016_bib34","series-title":"Disorders of hair growth: diagnosis and treatment","article-title":"Pattern hair loss","author":"Olsen","year":"2003"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2025.04.016_bib35","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000248891","article-title":"Effects of minoxidil on cultured human skin fibroblasts","volume":"175","author":"Pinnell","year":"1987","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2025.04.016_bib36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaad.2019.08.060","article-title":"Minoxidil 1 mg oral versus minoxidil 5% topical solution for the treatment of female-pattern hair loss: a randomized clinical trial","volume":"82","author":"Ramos","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib37","first-page":"1","article-title":"Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: a randomized controlled trial","volume":"00","author":"Asilian","year":"2023","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib89","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bjd.13873","article-title":"Hair shedding in women: how much is too much?","volume":"173","author":"Sinclair","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib90","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s13555-017-0171-8","article-title":"The hair shedding visual scale: a quick tool to assess hair loss in women","volume":"7","author":"Martinez-Velasco","year":"2017","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"Supp","key":"10.1016\/j.jaad.2025.04.016_bib39","first-page":"1145","article-title":"The bioavailability of 2% and 3% minoxidil topical solution relative to 2.5 mg oral tablet (Loniten-Upjohn)","volume":"3","author":"Szpunar","year":"1986","journal-title":"Pharm Res"},{"key":"10.1016\/j.jaad.2025.04.016_bib40","series-title":"Rogaine Minoxidil Topical Solution Monograph","year":"2003"},{"key":"10.1016\/j.jaad.2025.04.016_bib41","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/clpt.1990.55","article-title":"Influence of tretinoin on the percutaneous absorption of minoxidil from an aqueous topical solution","volume":"47","author":"Ferry","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaad.2025.04.016_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jps.2600790605","article-title":"Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution","volume":"79","author":"Ferry","year":"1990","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.jaad.2025.04.016_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.1989.46","article-title":"Absorption of minoxidil after topical application : effect of frequency and site of application","volume":"45","author":"Eller","year":"1989","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.jaad.2025.04.016_bib44","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/dth.12369","article-title":"Minoxidil topical treatment may be more efficient if applied on damp scalp in comparison with dry scalp","volume":"29","author":"Angelo","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2025.04.016_bib45","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/archderm.1985.01660020061018","article-title":"Percutaneous absorption of minoxidil in man","volume":"121","author":"Franz","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib46","series-title":"Product monograph 2% and 5% TMS and 5% TMF","year":"2017"},{"key":"10.1016\/j.jaad.2025.04.016_bib47","first-page":"328","article-title":"Molecular biology of the human cytosolic sulfotransferase gene superfamily implications in the bioactivation of minoxidil and cholesterol in skin","volume":"8","author":"Dooley","year":"1999","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib48","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1523-1747.ep12504905","article-title":"Minoxidil sulfate is the active metabolite that stimulates hair follicles","volume":"95","author":"Buhl","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib49","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2133.2004.05785.x","article-title":"Minoxidil: mechanisms of action on hair growth","volume":"150","author":"Messenger","year":"2004","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.016_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12688","article-title":"Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian subcontinent","volume":"31","author":"Chitalia","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2025.04.016_bib51","first-page":"817","article-title":"Identification of the sulfotransferase isoenzyme primarily responsible for the bio-activation of topical minoxidil","volume":"33","author":"McCoy","year":"2019","journal-title":"J Bio Regul Homeost Agents"},{"key":"10.1016\/j.jaad.2025.04.016_bib52","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/jocd.14299","article-title":"SULTA1 (minoxidil sulfotransferase) enzyme booster significantly improves response to topical minoxidil for hair regrowth","volume":"21","author":"Dhurat","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib53","first-page":"524","article-title":"Pilot study to evaluate the effect of topical betamethasone dipropionate on the percutaneous absorption of minoxidil from a 5% topical solution","volume":"94","author":"Ferry","year":"1990","journal-title":"J Invest Dermatol Abstracts"},{"key":"10.1016\/j.jaad.2025.04.016_bib54","first-page":"659","article-title":"Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes","volume":"34","author":"Sharma","year":"2020","journal-title":"Biol Regul Homeost Agents"},{"key":"10.1016\/j.jaad.2025.04.016_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2022.905140","article-title":"Efficacy and safety of 5% minoxidil alone, minoxidil plus oral spironolactone, and minoxidil plus microneedling on female pattern hair loss: a prospective, single-center, parallel-group, evaluator blinded, randomized trial","volume":"9","author":"Liang","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.jaad.2025.04.016_bib56","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/lsm.23398","article-title":"Low-level light therapy downregulates scalp inflammatory biomarkers in men with androgenetic alopecia and boosts minoxidil 2% to bring a sustainable hair regrowth activity","volume":"53","author":"Mahe","year":"2021","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2025.04.016_bib57","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.mjafi.2020.11.010","article-title":"Comparison of 5% minoxidil lotion monotherapy versus its combination with autologous platelet rich plasma in androgenetic alopecia in hundred males","volume":"77","author":"Ray","year":"2023","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.jaad.2025.04.016_bib58","unstructured":"Korberly BH, Amer F. Systemic bioavailablity and tolerability of minoxidil foam. Poster # 387 presented at the 61st AAD Annual Meeting; March 2003; San Francisco."},{"key":"10.1016\/j.jaad.2025.04.016_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1600-0536.1985.tb02597.x","article-title":"Contact dermatitis to minoxidil","volume":"13","author":"Tosti","year":"1985","journal-title":"Contact Derm"},{"key":"10.1016\/j.jaad.2025.04.016_bib60","article-title":"Contact sensitization to topically applied minoxidil solution: possible mechanism of action","volume":"33","author":"Castillo","year":"1985","journal-title":"Clin Res"},{"key":"10.1016\/j.jaad.2025.04.016_bib61","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jaad.2020.04.027","article-title":"How safe is prescribing oral minoxidil in patients allergic to topical minoxidil","volume":"86","author":"Therianou","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib62","unstructured":"Korberly BH, Spindler JR. Lack of cardiovascular effects of minoxidil topical solution in untreated hypertensives. Poster #388 presented at 61st AAD Dermatology Annual Meeting; March 2003; San Francisco."},{"key":"10.1016\/j.jaad.2025.04.016_bib63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0738-081X(88)90088-0","article-title":"The safety of topical minoxidil solution in the treatment of pattern baldness: the results of a 27-center trial","volume":"6","author":"Spindler","year":"1988","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib64","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1046\/j.1468-3083.2003.00621.x","article-title":"Hypertrichosis in females applying minoxidil topical solution and in normal controls","volume":"17","author":"Dawber","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2025.04.016_bib65","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12886-020-01499-6","article-title":"Minoxidil induced central serous chorioretinopathy treated with oral eplerenone-a case report","volume":"20","author":"Venkatesh","year":"2020","journal-title":"BMC Ophthamol"},{"key":"10.1016\/j.jaad.2025.04.016_bib66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/15569527.2011.613427","article-title":"Central chorioretinopathy associated with topical use of minoxidil 2% for treatment of baldness","volume":"32","author":"Scarinci","year":"2012","journal-title":"Cut Ocul Toxicol"},{"issue":"11","key":"10.1016\/j.jaad.2025.04.016_bib67","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.embor.7400003","article-title":"Potassium channel regulation","volume":"4","author":"Campbell","year":"2003","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jaad.2025.04.016_bib68","doi-asserted-by":"crossref","first-page":"148S","DOI":"10.1016\/0022-202X(93)90517-L","article-title":"Potassium channel conductance as a control mechanism in hair follicles","volume":"101","author":"Buhl","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib69","first-page":"685","article-title":"Tolerance of minoxidil after oral administration to normal volunteers","volume":"35","author":"Reele","year":"1984","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.jaad.2025.04.016_bib70","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaad.2022.05.026","article-title":"Prospective cardiovascular evaluation with 24-hour Holter and 24-hour ambulatory blood pressure monitoring in men using 5 mg oral minoxdil for androgenetic alopecia","volume":"88","author":"Sanabria","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib71","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/j.jaad.2022.06.1205","article-title":"Before-after study with 24-hour ambulatory blood pressure monitoring after the first dose of 5 mg oral minoxidil","volume":"87","author":"Jimenez-Caube","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ad.2023.07.019","article-title":"Safety of low-dose oral minoxidil in patients with hypertension and arrhythmia: a multicenter study of 264 patients","volume":"115","author":"Jimenez-Cauhe","year":"2024","journal-title":"Actas Dermo-Sifiliograficas"},{"key":"10.1016\/j.jaad.2025.04.016_bib74","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/(SICI)1099-081X(1998110)19:8<501::AID-BDD127>3.0.CO;2-G","article-title":"Pharmacokinetics of minoxidil in patients with cirrhosis and healthy volunteers","volume":"19","author":"Adams","year":"1998","journal-title":"Biopharm Drug Dispos"},{"issue":"6","key":"10.1016\/j.jaad.2025.04.016_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12741","article-title":"Low-dose daily aspirin reduces topical minoxidil efficacy in androgenetic alopecia patients","volume":"31","author":"Goren","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2025.04.016_bib75","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.jaad.2021.02.054","article-title":"Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients","volume":"84","author":"Vano-Galvan","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib76","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jaad.2020.11.035","article-title":"Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients","volume":"84","author":"Sanabria","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib77","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.16732","article-title":"The role of patient- and drug-related factors in oral minoxidil and pericardial effusion: analyses of data from the United States Food and Drug Administration Adverse Event Reporting System","volume":"24","author":"Gupta","year":"2025","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jdcr.2022.07.044","article-title":"Pericardial, pleural effusion and anasarca: a rare complication of low-dose oral minoxidil for hair loss","volume":"28","author":"Dlova","year":"2022","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaad.2025.04.016_bib79","doi-asserted-by":"crossref","first-page":"725","DOI":"10.36849\/JDD.8029","article-title":"Evaluation of pericardial efflusions in alopecia patients on low=dose oral minoxidil therapy","volume":"23","author":"Kincaid","year":"2024","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib80","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jaad.2020.08.124","article-title":"Characterization and management of hypertrichosis induced by low-dose oral minoxidil in the treatment of hair loss","volume":"84","author":"Jimenez-Cauhe","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib81","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.1975.03260030039018","article-title":"Severe hypertension. Treatment with minoxidil","volume":"233","author":"Mehta","year":"1975","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2025.04.016_bib82","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1067\/mjd.2003.325","article-title":"Pseudoacromegaly induced by the long-term use of minoxidil","volume":"48","author":"Nguyen","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib83","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaad.2019.08.018","article-title":"Pediatric androgenetic alopecia: a review","volume":"85","author":"Griggs","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib84","unstructured":"Trancik R, Spindler J, Cuddihy R et al. Clinician survey evaluating minoxidil topical solution in the treatment of androgenetic alopecia in patients under 18 years of age. Poster presented at 3rd Intercontinental Meeting of the Hair Research Societies; June 13-15, 2001; Tokyo, Japan."},{"key":"10.1016\/j.jaad.2025.04.016_bib85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000096924","article-title":"Topical use of minoxidil in children and systemic side effects","volume":"214","author":"Georgala","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2025.04.016_bib86","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jaad.2022.04.030","article-title":"Low-dose oral minoxidil for the treatment of androgenetic alopecia and telogen effluvium in a pediatric population: a descriptive study","volume":"87","author":"deNicolas-Ruanes","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib87","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jaad.2020.10.097","article-title":"Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls","volume":"84","author":"Olamiju","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib88","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/ijd.16373","article-title":"Systemic minoxidil for hair disorders in pediatric patients: a safety and tolerability review","volume":"62","author":"John","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2025.04.016_bib38","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s13555-024-01197-x","article-title":"Evaluation of the safety and efficacy of oral minoxidil in children: a systematic review","volume":"14","author":"Williams","year":"2024","journal-title":"Dermatol Ther"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222500605X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222500605X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T20:40:03Z","timestamp":1758660003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222500605X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S019096222500605X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2025.04.016","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Summation and recommendations for the safe and effective use of topical and oral minoxidil","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2025.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}